Natick, MA, United States of America

Seng H Cheng

USPTO Granted Patents = 70 

 

 

Average Co-Inventor Count = 4.6

ph-index = 18

Forward Citations = 1,035(Granted Patents)


Inventors with similar research interests:


Location History:

  • Bosaton, MA (US) (1999)
  • Boston, MA (US) (2006)
  • Bridgwater, NJ (US) (2017)
  • Wellesley, MA (US) (1997 - 2020)
  • Bridgewater, NJ (US) (2016 - 2022)
  • Natick, MA (US) (2013 - 2024)
  • Framingham, MA (US) (2014 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
70 patents (USPTO):

Title: Innovator Spotlight: Seng H Cheng - Pioneering Gene Therapy for Neurodegenerative Disorders

Introduction:

Seng H Cheng, an esteemed inventor based in Natick, MA, USA, has made significant contributions to the field of gene therapy and neurodegenerative disorders. With an impressive portfolio of 65 patents, Cheng has been at the forefront of developing groundbreaking treatments for conditions affecting motor function.

Latest Patents:

Cheng's latest patents showcase his innovative approach to addressing complex neurological challenges. One notable patent is centered around gene therapy for neurodegenerative disorders, focusing on treating motor function impairments caused by brain or spinal cord injuries. Another patent highlights his work on modulating Huntington expression to combat Huntington's disease and its associated symptoms.

Career Highlights:

Throughout his career, Cheng has held pivotal roles at reputable companies such as Genzyme Corporation and Ionis Pharmaceuticals, Inc. At these organizations, he has spearheaded research and development efforts aimed at revolutionizing the treatment landscape for neurological conditions. Cheng's dedication to advancing gene therapy technologies has earned him recognition as a trailblazer in the field.

Collaborations:

In his pursuit of scientific excellence, Cheng has collaborated closely with esteemed colleagues such as Lamya S Shihabuddin and John Marshall. Together, they have synergized their expertise to push the boundaries of innovation in gene therapy and neurodegenerative disorder research. Cheng's collaborative spirit and multidisciplinary approach have been instrumental in driving forward transformative solutions for patients in need.

Conclusion:

In conclusion, Seng H Cheng's visionary work in gene therapy and neurodegenerative disorders stands as a testament to his unwavering commitment to scientific advancement. Through his pioneering inventions and relentless pursuit of excellence, Cheng has positioned himself as a leading figure in the quest to enhance the quality of life for individuals affected by debilitating conditions. His impactful contributions continue to shape the landscape of medical innovation, offering hope for a brighter future in the realm of neurological healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…